N-(2-((S)-3-(((1r,4S)-4-hydroxy-4-(5-(pyrimidin-2-yl)pyridin-2-yl)cyclohexyl)amino)pyrrolidin-1-yl)-2-oxoethyl)-3-(trifluoromethyl)benzamide
95%
- Product Code: 218747
CAS:
1372407-07-2
| Molecular Weight: | 568.59 g./mol | Molecular Formula: | C₂₉H₃₁F₃N₆O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30478853 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry, closed |
Product Description:
Used as a potent inhibitor in pharmaceutical formulations targeting inflammatory diseases and autoimmune disorders. Its primary application lies in the development of treatments for rheumatoid arthritis and psoriasis due to its ability to selectively modulate immune cell signaling pathways. The compound demonstrates high efficacy in reducing cytokine production and T-cell activation, making it valuable in chronic inflammatory conditions. It is also investigated for use in oncology, particularly in hematological malignancies, where immune modulation plays a critical role. Due to its stability and bioavailability, it is suitable for oral dosage forms in clinical settings.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 10mg | 10-20 days | $2,741.72 |
+
-
|
| 50mg | 10-20 days | $8,773.50 |
+
-
|
N-(2-((S)-3-(((1r,4S)-4-hydroxy-4-(5-(pyrimidin-2-yl)pyridin-2-yl)cyclohexyl)amino)pyrrolidin-1-yl)-2-oxoethyl)-3-(trifluoromethyl)benzamide
Used as a potent inhibitor in pharmaceutical formulations targeting inflammatory diseases and autoimmune disorders. Its primary application lies in the development of treatments for rheumatoid arthritis and psoriasis due to its ability to selectively modulate immune cell signaling pathways. The compound demonstrates high efficacy in reducing cytokine production and T-cell activation, making it valuable in chronic inflammatory conditions. It is also investigated for use in oncology, particularly in hematological malignancies, where immune modulation plays a critical role. Due to its stability and bioavailability, it is suitable for oral dosage forms in clinical settings.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :